Indications: Type 2 diabetes mellitus (glycemic control) Cardiovascular risk reduction in type 2 diabetes with established CVD Contraindications: Personal/family history of medullary thyroid carcinoma (MTC) Patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Known hypersensitivity to semaglutide or any excipient Common Side Effects: Nausea (15.8%) Diarrhea (8.5%) Vomiting (5.0%) Abdominal pain , constipation , dyspepsia Hypoglycemia (especially with sulfonylureas or insulin) Injection site reactions Serious Risks: Pancreatitis Diabetic retinopathy complications Gallbladder disease Thyroid C-cell tumors Each OZEMPIC 0.5mg (Japanese) dose is a sterile, aqueous solution containing semaglutide and several inactive components that help maintain the stability and safety of the formulation
The data were extracted by two authors (SG and BS), and eligibility based on the predetermined inclusion criteria was assessed by both
The next few years will be critical in shaping this new landscape
68 Urinary miRNA-375 was also detected at high levels in that study
, B1, B6, Lysine, Methionine
However, many patients find that proper breathing, relaxation, and correct injection technique eliminate the need for numbing, especially after the first few doses when needle anxiety decreases naturally